+36.1%
MRNA vs ENB
+68.0%
-32.0%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | ENB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +5.4% | -1.0% | +6.3% | +5.0% |
| 7D | -1.1% | -4.7% | +3.6% | -2.8% |
| 30D | +126.1% | -5.9% | +132.0% | +121.4% |
| 3M | +190.0% | -14.2% | +204.3% | +188.5% |
| 6M | +157.2% | -8.6% | +165.8% | +150.7% |
| YTD | +388.2% | +3.9% | +384.3% | +352.7% |
| 1Y | +467.0% | +1.8% | +465.2% | +429.0% |
| 3Y | +36.1% | +68.5% | -32.4% | -4.4% |
| All | +36.1% | +68.0% | -32.0% | -4.4% |
Cumulative growth
Daily Returns
Daily percentage return beside ENB.
Daily Out/Under-Performance
Portfolio return minus ENB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ENB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded ENB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling